NDC 0093-7704 – Emtricitabine and Tenofovir Disoproxil Fumarate

Emtricitabine 200 mg/1; Tenofovir Disoproxil Fumarate 300 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC0093-7704

Product details

Brand name
Emtricitabine and Tenofovir Disoproxil Fumarate
Generic name
Emtricitabine and Tenofovir Disoproxil Fumarate
Labeler
Teva Pharmaceuticals USA, Inc.
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
ANDA · ANDA090894
Marketed since
January 20, 2021
Listing expires
December 31, 2026
Pharmacologic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Emtricitabine and tenofovir disoproxil fumarate →

Package NDC codes (1)

Package NDCDescriptionSince
0093-7704-5630 TABLET, FILM COATED in 1 BOTTLE (0093-7704-56)Jan 20, 2021

Other Emtricitabine and tenofovir disoproxil fumarate products